Just a few years ago, tech sector workers were hounded by recruiters hawking new openings. Now, workers face a daunting new ...

GoodRx Holdings (GDRX) shares have slipped about 27% over the past month, drawing investor attention to recent performance trends. The company’s ongoing path sparks questions about how current ...

Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q3 CY2025 results exceeding the market’s revenue expectations, but ...

The U.S. Food and Drug Administration recalled more than 140,000 bottles of a common statin medication. Is your medication ...

Q. On my last few trips, I developed severe nasal allergies and runny nose while on the plane. It was uncomfortable and embarrassing. Other travelers may have thought I had a bad cold or something ...

When it comes to weeds, procrastinating is never a good idea. The best way to get ahead of the invaders is to apply a pre-emergent product before winter weed seeds germinate. “If you do nothing, warm ...

GoodRx Holdings Inc. (NASDAQ:GDRX), a leading digital platform for prescription drug price comparisons, has recently seen volatile trading patterns, with a significant -12.72% decline over the past ...

GoodRx shares jumped this week after the company announced an expanded partnership with national retail pharmacy Kroger and following news about the launch of TrumpRx, a government-run, ...

Investing.com - GoodRx Holdings Inc. (NASDAQ:GDRX) shares jumped 19% on heavy trading volume Wednesday following news about a potential partnership with TrumpRx and an expanded relationship with ...

Oct 1 (Reuters) - GoodRx (GDRX.O), opens new tab said on Wednesday it has partnered with Kroger's (KR.N), opens new tab healthcare unit to expand its prescription savings services for branded drugs, ...

(Reuters) -GoodRx said on Wednesday it has partnered with Kroger's healthcare unit to expand its prescription savings services for branded drugs, including Novo Nordisk's popular weight-loss drug ...

GoodRx offers compelling value after a ~50% stock decline over the past 12 months, trading at just 6.1x FY25 adjusted EBITDA despite recent execution challenges. A new Novo Nordisk partnership for ...